Table 2

Adjusted HR of the statin category for new heart failure hospitalization according to the CAD and LDL categories

CAD category	LDL category	Statin category	Referent	HR	Lower CI	Upper CI	p Value	Number of patients	Number of events
ALL	ALL	Low	None	0.97	0.62	1.52	0.90	534	94
		Moderate	None	0.30	0.13	0.63	0.0008
		Moderate	Low	0.31	0.13	0.65	0.0014
	<100 mg/dL	Low	None	1.23	0.52	2.97	0.63	194	29
		Moderate	None	0.25	0.05	0.85	0.025
		Moderate	Low	0.20	0.04	0.66	0.007
	≥100 mg/dL	Low	None	0.88	0.50	1.52	0.66	340	65
		Moderate	None	0.40	0.13	0.97	0.042
		Moderate	Low	0.45	0.15	1.13	0.09
CAD (−)	ALL	Low	None	1.09	0.41	2.59	0.86	249	32
		Moderate	None	0.38	0.05	1.54	0.19
		Moderate	Low	0.35	0.05	1.70	0.20
	<100 mg/dL	Low	None	5.81	0.49	130	0.16	83	10
		Moderate	None	0.47	0.02	7.47	0.60
		Moderate	Low	0.08	0.00	3.03	0.18
	≥100 mg/dL	Low	None	0.91	0.28	2.53	0.87	166	22
		Moderate	None	0.41	0.02	2.63	0.39
		Moderate	Low	0.45	0.02	3.55	0.48
CAD (+)	ALL	Low	None	0.86	0.49	1.50	0.59	285	62
		Moderate	None	0.24	0.09	0.55	0.0006
		Moderate	Low	0.27	0.10	0.63	0.0015
	<100 mg/dL	Low	None	0.87	0.28	2.79	0.81	111	19
		Moderate	None	0.13	0.02	0.68	0.014
		Moderate	Low	0.15	0.02	0.64	0.008
	≥100 mg/dL	Low	None	0.80	0.39	1.59	0.52	174	43
		Moderate	None	0.30	0.08	0.87	0.026
		Moderate	Low	0.38	0.11	1.07	0.07

HRs were adjusted by age, sex, hypertension, ln [BNP (pg/mL)], HbA1c, eGFR and LDL cholesterol levels.
BNP, B-type natriuretic peptide; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; LDL, low-density lipoprotein.